Nicox SA (NICXF)
0.44
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nicox Total Assets (Quarterly): 58.56M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.56M |
| June 30, 2023 | 89.42M |
| June 30, 2023 | 89.42M |
| December 31, 2022 | 81.33M |
| June 30, 2022 | 103.67M |
| June 30, 2022 | 103.67M |
| December 31, 2021 | 129.76M |
| June 30, 2021 | 158.70M |
| June 30, 2021 | 158.70M |
| December 31, 2020 | 174.98M |
| June 30, 2020 | 167.68M |
| June 30, 2020 | 167.68M |
| December 31, 2019 | 159.97M |
| June 30, 2019 | 160.39M |
| June 30, 2019 | 160.39M |
| December 31, 2018 | 158.53M |
| June 30, 2018 | 169.97M |
| June 30, 2018 | 169.97M |
| December 31, 2017 | 180.92M |
| June 30, 2017 | 152.23M |
| June 30, 2017 | 152.23M |
| December 31, 2016 | 157.25M |
| June 30, 2016 | 155.46M |
| Date | Value |
|---|---|
| June 30, 2016 | 155.46M |
| December 31, 2015 | 178.59M |
| June 30, 2015 | 198.86M |
| June 30, 2015 | 198.86M |
| December 31, 2014 | 182.45M |
| June 30, 2014 | 75.41M |
| June 30, 2014 | 75.41M |
| December 31, 2013 | 99.67M |
| September 30, 2013 | 95.04M |
| June 30, 2013 | 97.11M |
| March 31, 2013 | 101.05M |
| December 31, 2012 | 111.28M |
| September 30, 2012 | 116.84M |
| June 30, 2012 | 117.04M |
| March 31, 2012 | 133.95M |
| December 31, 2011 | 124.13M |
| September 30, 2011 | 135.94M |
| June 30, 2011 | 148.45M |
| March 31, 2011 | 150.11M |
| December 31, 2010 | 150.20M |
| September 30, 2010 | 168.62M |
| June 30, 2010 | 169.59M |
| March 31, 2010 | 202.04M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
58.56M
Minimum
Dec 2023
174.98M
Maximum
Dec 2020
130.95M
Average
158.70M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 334.27M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 192.20M |
| Innate Pharma SA | 203.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.89M |
| Shareholders Equity (Quarterly) | 23.67M |
| Debt to Equity Ratio | 1.175 |
| Current Ratio | 8.967 |
| Net Debt Paydown Yield | -9.48% |